Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVaalco Energy Regulatory News (EGY)

Share Price Information for Vaalco Energy (EGY)

Share Price is delayed by 15 minutes
Get Live Data
415.00    5.00 (1.22%)
Bid:
390.00
Ask:
440.00
Spread: 50.00 (12.821%)
Market Cap: £444.10m
EGY Live PriceLast checked at - London Stock Exchange

Intraday Vaalco Energy Share Chart

PDMR Notification

8 Jun 2022 09:37

RNS Number : 1494O
Vaalco Energy Inc
08 June 2022
 

8 June 2022

PDMR Notification

VAALCO Energy, Inc. ("VAALCO" or "Company") announces that on 2 June 2022, restricted shares in the Company ("Common Shares") were transferred by the Company to persons discharging managerial responsibility in the Company as listed below, at the grant price of $8.31. The Common Shares will remain restricted for a period of one year from the date of transfer.

 

Name

Role

Nature of transaction

Number of Common Shares

Price per Common Share (US $)

Andrew Fawthrop

Director

Award of restricted shares of common stock

10,229

8.31

Catherine Stubbs

Director

Award of restricted shares of common stock

10,229

8.31

Fabrice Nze-Bekale

Director

Award of restricted shares of common stock

10,229

8.31

 

About VAALCO

 

VAALCO, founded in 1985, is a Houston, USA based, independent energy company with production, development and exploration assets in the West African region.

The Company is an established operator within the region, holding a 63.6%% working interest in the Etame Marin Block, located offshore Gabon, which to date has produced over 126 million barrels of crude oil and of which the Company is the operator.

For Further Information

VAALCO Energy, Inc. (General and Investor Enquiries)

+00 1 713 623 0801

 

 

Website:

www.vaalco.com

Al Petrie Advisors (US Investor Relations)

+00 1 713 543 3422

Al Petrie / Chris Delange

Buchanan (UK Financial PR)

 

+44 (0) 207 466 5000

Ben Romney / Jon Krinks James Husband

VAALCO@buchanan.uk.com

 

 

Notification of dealings in shares by PDMR's of the Company:

1.

Details of PDMR / PDMR Associate

(a) 

Name

Andrew Fawthrop

(b) 

Position / status

Director

(c)

Initial notification /

amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) 

Description of the financial instrument

Award of restricted shares of common stock

(b) 

Nature of the transaction

Award of restricted shares of common stock pursuant to the Company's 2020 Long Term Incentive Plan

(c)

Price(s) and volume(s)

Price: $8.31

Volume: 10,229

(US Dollar)

(d) 

Aggregated information

Aggregated volume

Price

 

 

Volume: 10,229

Price: $85,002.99

 

 

(e) 

Date of the transaction

2 June 2022

(f)

Place of the transaction

USA

 

 

 

 

1.

Details of PDMR / PDMR Associate

(a) 

Name

Catherine Stubbs

(b) 

Position / status

Director

(c)

Initial notification /

amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) 

Description of the financial instrument

Award of restricted shares of common stock

(b) 

Nature of the transaction

Award of restricted shares of common stock pursuant to the Company's 2020 Long Term Incentive Plan

(c)

Price(s) and volume(s)

Price: $8.31

Volume: 10,229

(US Dollar)

(d) 

Aggregated information

Aggregated volume

Price

 

 

Volume: 10,229

Price: $85,002.99

(e) 

Date of the transaction

2 June 2022

(f)

Place of the transaction

USA

 

1.

Details of PDMR / PDMR Associate

(a) 

Name

Fabrice Nze-Bekale

(b) 

Position / status

Director

(c)

Initial notification /

amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a) 

Description of the financial instrument

Award of restricted shares of common stock

(b) 

Nature of the transaction

Award of restricted shares of common stock pursuant to the Company's 2020 Long Term Incentive Plan

(c)

Price(s) and volume(s)

Price: $8.31

Volume: 10,229

(US Dollar)

(d) 

Aggregated information

Aggregated volume

Price

 

 

Volume: 10,229

Price: $85,002.99

 

 

(e) 

Date of the transaction

2 June 2022

(f)

Place of the transaction

USA

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFVTREITIIF
Date   Source Headline
8th May 20267:01 amRNSFIRST QUARTER 2026 RESULTS
8th May 20267:00 amRNSSECOND QUARTER 2026 DIVIDEND
5th May 20267:00 amRNSQ1'26 Earnings Release and Conference Call
27th Apr 20267:00 amRNSANNUAL REPORT PUBLICATION & PROXY STATEMENT ISSUE
21st Apr 20267:00 amRNSOperational Update
15th Apr 20267:00 amRNSParticipation in Water Tower Research Conference
13th Mar 20267:00 amRNSQ4 & FY 2025 RESULTS
13th Mar 20267:00 amRNSQ4 & FY 2025 RESULTS
9th Mar 20267:30 amRNSOperational Update
6th Mar 20267:00 amRNSQ4 & FY25 Earnings Release and Conference Call
25th Feb 20267:00 amRNSParticipation in SB1 Markets Energy Conference
24th Feb 20267:00 amRNSOperational Update
17th Feb 20267:00 amRNSFIRST QUARTER 2026 DIVIDEND
13th Feb 20267:00 amRNSNon-deal roadshow & updated investor presentation
5th Feb 20267:00 amRNSAgreement to divest non-core asset
15th Jan 20267:00 amRNSOperational and Financial Update
9th Dec 20257:00 amRNSCommencement of Drilling Program Offshore Gabon
21st Nov 20257:00 amRNS-RVaalco Energy & Water Tower Research
11th Nov 20257:01 amRNSFOURTH QUARTER 2025 DIVIDEND
11th Nov 20257:00 amRNSTHIRD QUARTER 2025 RESULTS
20th Oct 20257:00 amRNSQ3'25 Earnings Release & Conference Call
8th Aug 20257:01 amRNSTHIRD QUARTER 2025 DIVIDEND
8th Aug 20257:00 amRNSSECOND QUARTER 2025 RESULTS
28th Jul 20257:00 amRNSQ2'25 Earnings Release & Conference Call
25th Jun 20251:09 pmRNSReport on Payments to Governments
12th Jun 20257:00 amRNSPDMR dealings
9th May 20257:03 amRNSFIRST QUARTER 2025 RESULTS
8th May 20257:00 amRNSSECOND QUARTER 2025 DIVIDEND
7th May 20257:00 amRNSCapital Markets Day Update
29th Apr 20257:00 amRNSQ1'25 Earnings Release & Conference Call
28th Apr 20257:00 amRNSANNUAL REPORT PUBLICATION & PROXY STATEMENT ISSUE
31st Mar 20257:00 amRNS-RInvestor Meet Company Presentation
27th Mar 20257:00 amRNSCapital Markets Day
26th Mar 20257:00 amRNSPDMR dealings
17th Mar 20257:00 amRNSPDMR dealings
14th Mar 20257:00 amRNSQ4 & FY 2024 RESULTS AND YEAR-END 2024 RESERVES
5th Mar 20257:00 amRNSNew $300 million revolving credit facility
4th Mar 20257:00 amRNSQ4 & FY24 Earnings Release and Conference Call
3rd Mar 20257:00 amRNSAcquisition of interest in CI-705 Block
19th Feb 20257:00 amRNSFIRST QUARTER 2025 DIVIDEND
3rd Feb 20257:00 amRNSFPSO REFURBISHMENT PROJECT
21st Jan 20257:00 amRNSRECORD PRODUCTION AND SALES VOLUMES FOR 2024
18th Dec 20247:00 amRNSPDMR Dealings
11th Dec 20247:00 amRNSVAALCO SECURES RIG FOR 2025/26 DRILLING CAMPAIGN
12th Nov 20247:00 amRNSTHIRD QUARTER 2024 RESULTS
11th Nov 20247:00 amRNSFOURTH QUARTER 2024 DIVIDEND
25th Oct 20247:00 amRNSQ3’24 Earnings Release and Conference Call
7th Aug 20247:24 amRNSSECOND QUARTER 2024 RESULTS
6th Aug 20247:00 amRNSTHIRD QUARTER 2024 DIVIDEND
26th Jul 20247:00 amRNSQ2’24 Earnings Release and Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.